SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Auro Laboratories gets nod for capacity expansion

23 Aug 2023 Evaluate

Auro Laboratories has received approval for a capacity expansion in the existing unit of the Company. The proposed Capacity is expected to be added by March 31, 2024 and investment required for the said capacity expansion is around Rs 40 crore. Mode of Financing is Internal Accruals and Term Loan from Bank. The Board of Directors of the Company, at their meeting held on August 23, 2023, has approved the same. 

Auro Laboratories incorporated in 1989 is engaged in business of manufacturing active pharmaceutical ingredients (API's), intermediates and generic formulations. 


Auro Laboratories Share Price

261.20 -8.50 (-3.15%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×